These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 26648079)

  • 21. Role of immunotherapy in the treatment of bladder and renal cell carcinoma.
    Stone NN; Droller MJ
    Semin Surg Oncol; 1991; 7(4):239-43. PubMed ID: 1925256
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combination immunotherapy in genitourinary malignancies.
    Hoffman-Censits J; Wilde L
    Curr Opin Urol; 2016 Nov; 26(6):523-8. PubMed ID: 27517637
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bibliography. Current world literature. Genitourinary system.
    Curr Opin Oncol; 1999 May; 11(3):B116-30. PubMed ID: 10328603
    [No Abstract]   [Full Text] [Related]  

  • 24. Novel immunotherapy combinations for genitourinary cancers.
    Al Harthy M; Redman J; Madan RA
    Expert Opin Biol Ther; 2020 Mar; 20(3):253-262. PubMed ID: 31914333
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genitourinary malignancy.
    Giantonio B; Ozols RF; Hudes GR
    Cancer Chemother Biol Response Modif; 1993; 14():498-529. PubMed ID: 8312117
    [No Abstract]   [Full Text] [Related]  

  • 26. The effects of treatment on delayed cutaneous hypersensitivity responses (DNCB, croton oil, and recall antigen) in patients with genitourinary cancer.
    Elhilali MM; Brosman SA; Vescera C; Paul JG; Fahey JL
    Cancer; 1978 May; 41(5):1765-70. PubMed ID: 647626
    [No Abstract]   [Full Text] [Related]  

  • 27. Editorial: Emerging Immunotargets in Genitourinary Tumors.
    Montironi R; Santoni M; Massari F; Lopez-Beltran A; Cheng L; Berardi R; Scarpelli M
    Curr Drug Targets; 2016; 17(7):748-9. PubMed ID: 27086839
    [No Abstract]   [Full Text] [Related]  

  • 28. Genitourinary Cancer: Updates on Treatments and Their Impact on the Kidney.
    Orozco Scott P; Deshpande P; Abramson M
    Semin Nephrol; 2022 Nov; 42(6):151344. PubMed ID: 37172546
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic approaches for lymph node involvement in prostate, bladder and kidney cancer.
    Stabile A; Muttin F; Zamboni S; Moschini M; Gandaglia G; Fossati N; Dell'Oglio P; Capitanio U; Cucchiara V; Mazzone E; Bravi CA; Mirone V; Montorsi F; Briganti A
    Expert Rev Anticancer Ther; 2019 Sep; 19(9):739-755. PubMed ID: 31469021
    [No Abstract]   [Full Text] [Related]  

  • 30. Immunology of genitourinary tumors.
    Guinan P; Sadoughi N; Bush IM; John T; Eghrari F; Ablin RJ
    Urology; 1973 Nov; 2(5):493-9. PubMed ID: 4131868
    [No Abstract]   [Full Text] [Related]  

  • 31. Immunologic features of genitourinary cancer.
    Javadpour N
    Urology; 1973 Aug; 2(2):103-8. PubMed ID: 4129366
    [No Abstract]   [Full Text] [Related]  

  • 32. [Update uro-oncology: scientific meetings 2011].
    Hegele A; Skrobek L; Schrader AJ
    Aktuelle Urol; 2012 Jan; 43(1):13-27. PubMed ID: 22344822
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sarcomatoid lesions of the urogenital tract.
    Reuter VE
    Semin Diagn Pathol; 1993 May; 10(2):188-201. PubMed ID: 8367626
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The studies of natural killer cell activity in uro-genital cancer patients--investigation of natural killer cell activity from the standpoint of stage and antitumor therapy of genito-urinary tract carcinomas].
    Fukasawa K
    Nihon Hinyokika Gakkai Zasshi; 1988 Feb; 79(2):239-45. PubMed ID: 3226000
    [No Abstract]   [Full Text] [Related]  

  • 35. Inside the 2015 ASCO Genitourinary Cancers Symposium.
    Santoni M; Massari F; Iacovelli R; Ciccarese C; Verri E; Burattini L; Montironi R; Nolè F; Tortora G; Cascinu S
    Future Oncol; 2015; 11(13):1859-62. PubMed ID: 26161923
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genitourinary cancer in the elderly.
    Mulholland SG; Stefanelli JL
    Am J Kidney Dis; 1990 Oct; 16(4):324-8. PubMed ID: 2220779
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biologic tools to personalize treatment in genitourinary cancers.
    Bracarda S; Sisani M; Del Buono S; Ishiwa O; Montagnani F;
    Crit Rev Oncol Hematol; 2012 Dec; 84 Suppl 1():e42-8. PubMed ID: 21232974
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Microbiome and Genitourinary Cancer: A Collaborative Review.
    Markowski MC; Boorjian SA; Burton JP; Hahn NM; Ingersoll MA; Maleki Vareki S; Pal SK; Sfanos KS
    Eur Urol; 2019 Apr; 75(4):637-646. PubMed ID: 30655087
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activities and accomplishments of the cancer and leukemia group B genitourinary committee.
    Small EJ; Halabi S; Kantoff P; D'Amico A; Stadler W; Kelley WK; Mohler J; Bajorin D; Vogelzang NJ
    Clin Cancer Res; 2006 Jun; 12(11 Pt 2):3596s-600s. PubMed ID: 16740791
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Combination radiotherapy-immunotherapy in genitourinary cancer].
    Ollivier L; Guimas V; Rio E; Vaugier L; Masson I; Libois V; Labbé M; Fradin D; Potiron V; Supiot S
    Cancer Radiother; 2021 Oct; 25(6-7):565-569. PubMed ID: 34391648
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.